November 24, 2020
2 min watch
Save
VIDEO: Dual action of faricimab yields positive results in DME, AMD
In this Healio Video Perspective from the virtual AAO annual meeting, David A. Eichenbaum, MD, discusses evidence from BOULEVARD and STAIRWAY phase 2 studies informing further research of faricimab for treatment of retinal diseases.
Published by:
Sources/Disclosures
Collapse
Source:
Eichenbaum, DA, et al. Faricimab: Evidence for differentiation with dual angiopoietin-2 (Ang-2)/VEGF-A inhibition in DME and nAMD. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).